OPtimal Type 2 dIabetes Management Including Benchmarking and Standard Treatment in CEEMEA (OPTIMISE)
Status
Completed
Conditions
Diabetes Mellitus, Non-Insulin-Dependent
Details and patient eligibility
About
OPTIMISE-CEEMEA is a multinational, multi-centre, observational, prospective study which will include patients suffering from diabetes type 2, treated or untreated, insulin dependent or not insulin dependent.
In this study we aim to explore at a primary care level whether the use of benchmarking against a set of guideline-based reference values on a patient basis, may improve quality of patient care, in particular control of diabetes, lipids and blood pressure.
Enrollment
733 patients
Sex
All
Ages
18+ years old
Volunteers
No Healthy Volunteers
Inclusion criteria
- Subjects suffering from diabetes type 2,
- treated or untreated,
- insulin dependent or not insulin dependent Able to read and send SMS (if SMS applicable)
Exclusion criteria
- Type 1 diabetes Pregnancy diabetes
- Hospitalization at the moment of enrollment in the study
Trial design
733 participants in 1 patient group
Patients with diabetes type 2
Trial contacts and locations
20
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems